Tissue distribution and cytochrome P450 inhibition of sesaminol and its tetrahydrofuranoid metabolites

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 35, 2012, Pages 8616-8623

  Jan, Kuo Ching ^a   Chang, Yi Wei ^b   Hwang, Lucy Sun ^c   Ho, Chi Tang ^c,d  

^a FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^b SunTen Phytotech Inc   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

cytochrome P450; sesaminol; tetrahydrofuranoid lignans; tissue distribution

Indexed keywords

CYP2C19; CYTOCHROME P450; ENTEROLACTONE; GLUCURONIDES; IN-VIVO; LIGNANS; MAMMALIAN LIGNANS; MULTIPLE FUNCTION; POTENT INHIBITION; SESAME OIL; SESAMIN; SESAMINOL; TISSUE DISTRIBUTIONS;

METABOLITES; RATS; TISSUE; VEGETABLE OILS;

BIOMOLECULES;

1,3 DIOXOLANE DERIVATIVE; CYTOCHROME P450; ENZYME INHIBITOR; FURAN DERIVATIVE; SESAMINOL;

ANIMAL; ARTICLE; BIOAVAILABILITY; DRUG ANTAGONISM; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL AVAILABILITY; CYTOCHROME P-450 ENZYME SYSTEM; DIOXOLES; ENZYME INHIBITORS; FURANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

MAMMALIA; RATTUS; SESAMUM INDICUM;

EID: 84865859300     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf302699f     Document Type: Article

References (34)

1. Webb, A. L.; McCullough, M. L. Dietary lignans: potential role in cancer prevention Nutr. Cancer 2005, 51, 117-131 (Pubitemid 40734711)
2. Papadakis, E. N.; Lazarou, D.; Grougnet, R.; Magiatis, P.; Skaltsounis, A. L.; Papadopoulou-Mourkidou, E.; Papadopoulos, A. I. Effect of the form of the sesame-based diet on the absorption of lignans Br. J. Nutr. 2008, 100, 1213-1219
3. Jan, K. C.; Ku, K. L; Chu, Y. H.; Hwang, L. S.; Ho, C. T. Tissue distribution and elimination of estrogenic and anti-inflammatory catechol metabolites fromsesaminol triglucoside in rats J. Agric. Food Chem. 2010, 58, 7693-7700
4. Jan, K. C.; Hwang, L. S.; Ho, C. T. Biotransformation of sesaminol triglucoside to mammalian lignans by intestinal microbiota J. Agric. Food Chem. 2009, 57, 6101-6106
5. Wan, C. K.; Zhu, G. Y.; Shen, X. L.; Chattopadhyay, A.; Dey, S.; Fong, W. F. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells Biochem. Pharmacol. 2006, 72, 824-837 (Pubitemid 44301053)
6. Sun, M.; Xu, X. L.; Lu, Q. H.; Pan, Q. R.; Hu, X. Schisandrin B: a dual inhibitor of P glycoprotein and multidrug resistance-associated protein 1 Cancer Lett. 2007, 246, 300-307 (Pubitemid 44959402)
7. Pan, Q. R.; Tao, W.; Lu, Q. H.; Hu, X. Schisandrin B - a novel inhibitor of P glycoprotein Biochem. Biophys. Res. Commun. 2005, 335, 406-411
8. Pan, Q. R.; Lu, Q. H.; Zhang, K.; Hu, X. Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein Cancer Chemother. Pharmacol. 2006, 58, 99-106
9. Lakehal, F.; Dansette, P. M.; Becquemont, L.; Lasnier, E.; Delelo, R.; Balladur, P.; Poupon, R.; Beaune, P. H.; Housset, C. Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes Chem. Res. Toxicol. 2001, 14, 694-701 (Pubitemid 32565719)
10. Bressler, R. Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs Geriatrics 2006, 61, 12-18
11. Dresser, G. K.; Spence, J. D.; Bailey, D. G. Pharmacokinetic- pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition Clin. Pharmacokinet. 2000, 38, 41-57 (Pubitemid 30055093)
12. Adlercreutz, H.; van der Wildt, J.; Kinzel, J.; Attalla, H.; Wahala, K.; Makela, T.; Hase, T.; Fotsis, T. Lignan and isoflavonoid conjugates in human urine J. Steroid Biochem. Mol. Biol. 1995, 52, 97-103
13. Burchell, B.; Brierley, C. H.; Rance, D. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation Life Sci. 1995, 57, 1819-1831
14. Obach, R. S. Inhibition of human cytochrome P450 enzymes by constituents of St. John's wort, an herbal preparation used in the treatment of depression J. Pharmacol. Exp. Ther. 2000, 294, 88-95 (Pubitemid 30434674)
15. Yasuda, K.; Ikushiro, S. I.; Wakayama, S.; Itoh, T.; Yamamoto, K.; Kamakura, M.; Munetsuna, E.; Ohta, M.; Sakaki, T. Comparison of metabolism of sesamin and episesamin by drug metabolizing enzymes in human liver. Drug Metab. Dispos. 2012, 29.
16. Yasuda, K.; Ikushiro, S.; Kamakura, M.; Munetsuna, E.; Ohta, M.; Sakaki, T. Sequential metabolism of sesamin by cytochrome P450 and UDP- glucuronosyltransferase in human liver Drug Metab. Dispos. 2011, 39, 1538-1545
17. Yasuda, K.; Ikushiro, S.; Kamakura, M.; Ohta, M.; Sakaki, T. Metabolism of sesamin by cytochrome P450 in human liver microsomes Drug Metab. Dispos. 2010, 38, 2117-2123
18. Katsuzaki, H.; Kawakishi, S.; Osawa, T. Sesaminol glucosides in sesame seeds Phytochemistry 1994, 35, 773-776 (Pubitemid 2044285)
19. Jan, K. C.; Hwang, L. S.; Ho, C. T. Tissue distribution and elimination of sesaminol triglucoside and its metabolites in rat Mol. Nutr. Food Res. 2009, 53, 815-825
20. Jan, K. C.; Ho, C. T.; Hwang, L. S. Bioavailability and tissue distribution of sesamol in rat J. Agric. Food Chem. 2008, 56, 7032-7037
21. Kuo, J. H.; Jan, M. S.; Lin, Y. L.; Lin, C. Interactions between octaarginine and U-937 human macrophages: global gene expression profiling, superoxide anion content, and cytokine production J. Controlled Release 2009, 139, 197-204
22. Jan, K. C.; Ku, K. L.; Chu, Y. H.; Hwang, L. S.; Ho, C. T. Intestinal distribution and excretion of sesaminol and its tetrahydrofuranoid metabolites in rats J. Agric. Food Chem. 2011, 59, 3078-3086
23. Papadakis, E. N.; Lazarou, D.; Grougnet, R.; Magiatis, P.; Skaltsounis, A. L.; Papadopoulou-Mourkidou, E.; Papadopoulos, A. I. Effect of the form of the sesame-based diet on the absorption of lignans Br. J. Nutr. 2008, 100, 1213-1219
24. Mochizuki, M.; Tsuchie, Y.; Nakamura, Y.; Osawa, T. Identification and characterization of sesaminol metabolites in the liver J. Agric. Food Chem. 2009, 57, 10429-10434
25. Guidance for Industry: Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling; Food and Drug Administration: Washington, DC, 2006.
26. Tirona, R. G.; Bailey, D. G. Herbal product-drug interactions mediated by induction Br. J. Clin. Pharmacol. 2006, 61, 677-681 (Pubitemid 43794793)
27. Usia, T.; Watabe, T.; Kadota, S.; Tezuka, Y. Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl lignans of Piper cubeba: mechanism-based inhibition Life Sci. 2005, 76, 2381-2391 (Pubitemid 40313425)
28. Ikeda, S.; Tohyama, T.; Yamashita, K. Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl-2(2′-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed γ-tocopherol J. Nutr. 2002, 132, 961-966 (Pubitemid 34495445)
29. Parker, R. S.; Sontag, T. J.; Swanson, J. E. Cytochrome P450 3A-dependent metabolism of tocopherols and inhibition by sesamin Biochem. Biophys. Res. Commun. 2000, 277, 531-534
30. Zuber, R.; Modriansky, M.; Dvorak, Z.; Rohovsky, P.; Ulrichova, J.; Simanek, V.; Anzenbacher, P. Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities Phytother. Res. 2002, 16, 632-638 (Pubitemid 35334183)
31. Dvorak, Z.; Vrzal, R.; Ulrichova, J. Silybin and dehydrosilybin inhibit cytochrome P450 1A1 catalytic activity: a study in human keratinocytes and human hepatoma cells Cell Biol.Toxicol. 2006, 22, 81-90 (Pubitemid 43376192)
32. Agarwal, R.; Wang, Z. Y.; Bik, D. P.; Mukhtar, H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes Drug Metab. Dispos. 1991, 19, 620-624
33. Liu, K. T.; Cresteil, T.; Columelli, S.; Lesca, P. Pharmacological properties of dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae chinensis. II. Induction of phenobarbital-like hepatic monooxygenases Chem.-Biol. Interact. 1982, 39, 315-330 (Pubitemid 12153566)
34. Metsugi, Y.; Miyaji, Y.; Ogawara, K.; Higaki, K.; Kimura, T. Appearance of doublepeaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function Pharm. Res. 2008, 25, 886-895 (Pubitemid 351661842)